Skip to main content
UPXI logo

UPXI · Upexi, Inc. · Documents

Track UPXI — free
$0.55 -0.01 (-2.18%) At close · Nov 19 Play latest call Q4 2026 earnings call transcript
Market Cap
$48.72M
Shares
88.86M
Volume · Nov 19 1.02M Avg daily vol (3M) 3.1M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report FY2026 Revenue $25M up 58.1% 10-K filed Sep 17, 2026 Quarterly report FY2027 Q1 Revenue $3.48M down 62.3% 10-Q filed Nov 10, 2026 Latest results Net income totaled $89.1 million amid digital-asset gains 8-K filed Nov 12, 2026 Earnings call Q4 2026 earnings call Held Sep 17, 2026
2026
Nov 12
Current report 8-K Events of Nov 10
Net income totaled $89.1 million amid digital-asset gains

Upexi reported $89.1 million net income, or $0.68 per diluted share, for the quarter ended September 30, 2026, driven largely by $102.0 million of unrealized digital-asset gains. Revenue was approximately $3.5 million; the treasury held approximately 2.35 million SOL.

Financial results
5 source passages
Upexi, Inc. (NASDAQ: UPXI) (the “Company” or “Upexi”), a leading Solana-focused digital asset treasury company and consumer brands owner, today announced its financial results for the fiscal first quarter ended September 30, 2026. Net income totaled $89.1 million, or $0.97 per basic share and $0.68 per diluted share, compared to net income of $66.7 million, or $1.21 per basic share and $0.76 per diluted share, for the quarter ended September 30, 2025. Net income was largely driven by $102.0 million of unrealized gains on digital assets, reflecting non-cash quarter-end fair value adjustments. Total revenue for the quarter was approximately $3.5 million, compared to $9.2 million for the quarter ended September 30, 2025. Total SOL held of approximately 2.35 million as of September 30, 2026, with an average cost of approximately $154 per SOL. Open the document at this passage
Nov 10
Quarterly report 10-Q FY2027 Q1, ended Sep 30
Profit rises sharply as revenue contracts

Upexi reported net income of $89,123,174 versus $66,748,122 for the three months ended September 30, 2026, as revenue fell 86.3% and digital asset revenue declined approximately $3.0 million.

Revenue $3.48M ▼ 62.3% Net income $89.12M ▲ 33.5% Diluted EPS $0.68 ▼ 10.5%
Read from the MD&A section
5 source passages
Net income | 89,123,174 | | 66,748,122 | | 22,375,052 Revenue declined by approximately $2.7 million, or 86.3%, as compared with the same period last year, primarily due to the Company’s shift away from legacy health, wellness and other consumer-product lines and the exit of certain manufacturing and distribution operations. Digital asset revenue decreased by approximately $3.0 million as compared with the same period last year, primarily due to lower SOL token prices during the current period. The following summary of the Company’s operations should be read in conjunction with its unaudited condensed consolidated financial statements for the three months ended September 30, 2026 and 2025, which are included herein. On November 26, 2025, Upexi, Inc. filed for arbitration against GSR Strategies LLC (“GSR”). Open the document at this passage
Oct 13
Current report 8-K
Regulation FD disclosure

Upexi, Inc. will use its Fall 2026 investor presentation for upcoming investor conferences and meetings with investors and other interested parties.

Oct 13
Proxy statement DEF 14A Meeting Nov 24, 2026
Proxy statement

Upexi, Inc. seeks shareholder approval on November 24, 2026 for issuances under July 16, 2025 and January 9, 2026 secured convertible notes, and one or more reverse stock splits ranging from 1:2 to 1:4, to address Nasdaq compliance issues.

Read from the first part of this long document
Oct 7
Current report 8-K Events of Oct 6
Other events

Upexi announced Chief Strategy Officer Brian Rudick will participate in Maxim Growth Summit 2026, the Webull Emerging & Innovative Companies Webinar, and the LD Micro 20th Annual Main Event during October 2026.

Sep 29
Proxy statement PRE 14A Meeting Nov 24, 2026
Proxy statement

Upexi, Inc. seeks shareholder approval for share issuances under notes dated July 16, 2025 and January 9, 2026 to address Nasdaq Listing Rule 5635(a), and authorization for one or more reverse stock splits ranging from 1:2 to 1:4.

Read from the first part of this long document
Sep 17
Annual report 10-K FY2026, ended Jun 30
Annual report for FY2026 AI summary on its way
Revenue $25M ▲ 58.1% Net loss $246.06M Diluted EPS -$3.87
Sep 9
Current report 8-K Events of Sep 8
Other events AI summary on its way
Jun 30
Current report 8-K
Other events AI summary on its way
May 12
Quarterly report 10-Q FY2026 Q3, ended Mar 31
Quarterly report for FY2026 Q3 AI summary on its way
Revenue $4.56M ▲ 44.2% Net loss $109.34M Diluted EPS -$1.67
May 5
Proxy statement DEF 14A Meeting Jun 15, 2026
Proxy statement AI summary on its way
Feb 10
Quarterly report 10-Q FY2026 Q2, ended Dec 31
Quarterly report for FY2026 Q2 AI summary on its way
Revenue $8.05M ▲ 101.0% Net loss $178.92M
Jan 9
Current report 8-K Events of Jan 7
Other events AI summary on its way
2025
Nov 12
Quarterly report 10-Q FY2026 Q1, ended Sep 30
Quarterly report for FY2026 Q1
Revenue $9.24M ▲ 112.1% Net income $66.75M Diluted EPS $0.76 ▼ 51.0%
Showing 1–50 of 255 documents
Key facts CIK 1775194 CUSIP 39959A205 13F (30d) 59 filings 54 filers Visit website Investor relations